Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission
Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage …
Background Sharing of equipment used for injecting drug use (IDU) is a substantial cause of
disease burden and a contributor to blood-borne virus transmission. We did a global …
disease burden and a contributor to blood-borne virus transmission. We did a global …
Global cancer in women: burden and trends
This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …
Deep learning and social network analysis elucidate drivers of HIV transmission in a high-incidence cohort of people who inject drugs
SJ Clipman, SH Mehta, S Mohapatra… - Science …, 2022 - science.org
Globally, people who inject drugs (PWID) experience some of the fastest-growing HIV
epidemics. Network-based approaches represent a powerful tool for understanding and …
epidemics. Network-based approaches represent a powerful tool for understanding and …
Inhibition of secretin/secretin receptor axis ameliorates NAFLD phenotypes
Background and Aims Human NAFLD is characterized at early stages by hepatic steatosis,
which may progress to NASH when the liver displays microvesicular steatosis, lobular …
which may progress to NASH when the liver displays microvesicular steatosis, lobular …
High HIV burden among people who inject drugs in 15 Indian cities
GM Lucas, SS Solomon, AK Srikrishnan, A Agrawal… - Aids, 2015 - journals.lww.com
Background: Injecting drug use has historically been the principal driver of the HIV epidemic
in the northeast states of India. However, recent data indicate growing numbers of people …
in the northeast states of India. However, recent data indicate growing numbers of people …
HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India
L Ray Saraswati, A Sarna, MP Sebastian, V Sharma… - BMC public health, 2015 - Springer
Background India has large PWID (persons who inject drugs) population estimated at
177,000. PWIDs are at high risk for HIV, Hepatitis B (HBV) and Hepatitis C (HCV) infections …
177,000. PWIDs are at high risk for HIV, Hepatitis B (HBV) and Hepatitis C (HCV) infections …
Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio‐behavioural surveillance survey in 2015
G Moradi, MM Gouya… - Tropical Medicine & …, 2018 - Wiley Online Library
Objectives To provide more accurate estimates of the prevalence of Hepatitis B (HBV) and
Hepatitis C (HCV) and their contributing factors among prisoners in Iran. Methods Cross …
Hepatitis C (HCV) and their contributing factors among prisoners in Iran. Methods Cross …
Outcomes of real-world integrated HCV microelimination for people who inject drugs: an expansion of the Punjab model
Background The prevalence of chronic hepatitis C (CHC) in People Who Inject Drugs
(PWID) is 8-10% as compared to 3· 6% in the general population in Punjab, India. We …
(PWID) is 8-10% as compared to 3· 6% in the general population in Punjab, India. We …
Molecular mechanisms of hepatocarcinogenesis following sustained virological response in patients with chronic hepatitis C virus infection
CN Hayes, P Zhang, Y Zhang, K Chayama - Viruses, 2018 - mdpi.com
Despite the success of direct-acting antiviral (DAA) agents in treating chronic hepatitis C
virus (HCV) infection, the number of cases of HCV-related hepatocellular carcinoma (HCC) …
virus (HCV) infection, the number of cases of HCV-related hepatocellular carcinoma (HCC) …